Overview
When it comes to the life sciences industry, two things are clear: The landscape of health care is rapidly changing. And to remain successful, companies must continue to seek the highest standards of innovation while managing all of the evolving issues that come with today’s new operating environment – from increasing regulatory scrutiny to heightened competition from generic providers.
The attorneys of Nexsen Pruet understand the trends reshaping the life sciences industry and have the experience and backgrounds necessary to handle the gamut of concerns facing pharmaceutical, biotechnology, medical device, and health care service companies.
We help clients stay at the forefront of advancements and breakthroughs in medical care by employing legal strategies that support virtually every phase of a company’s development and product lifecycle.
Clients in the life sciences industry turn to us for our broad-based knowledge in:
- Intellectual property licensing, protection, and enforcement, including issues with patents, copyrights, and trademarks
- Mergers and acquisitions
- Structuring and negotiating corporate alliances, partnerships, and collaborations
- Evaluations of capital projects
- Public and private equity and debt financings
- General securities and corporate governance/compliance matters
- Research and development financings
- Technology licensing and contracts
- Compliance with marketing programs, research and development initiatives, regulations and regulatory entities, and tax law
- Litigation
Regulatory Experience
We help clients understand the laws and regulations applying to industries working in the chemistry, biotech and pharmaceutical areas. We assist in securing the required permits or licenses from local, state and federal agencies. We also assist clients with government inspections and government representation.
The federal agencies we have experience working with include:
- Food and Drug Administration
- Department of Transportation
- Environmental Protection Agency
- Bureau of Alcohol Tobacco and Firearms
- Occupational Safety and Health Administration
- Department of Agriculture
- Drug Enforcement Administration
Life Sciences Webinar Series
Current Session:
Session 8 | Coming in 2022: Stay Tuned!
Past Sessions:
Session 1 | Corporate Issues Affecting Life Sciences Companies (March 31st)
- Presented by: Matthew Roberts and Jones DuBose of Nexsen Pruet
Session 2 | Onshoring of the Life Sciences Industry: Targeted Economic Development Strategies (April 28th)
- Presented by: Tushar Chikhliker of Nexsen Pruet and Sam Konduros of SCBIO
Session 3 | Offensive and Defensive Strategies for Protecting Your Company's Trade Secrets (May 27th)
- Presented by: Jennie Cluverius and Nikole Mergo of Nexsen Pruet and Lou Kennedy of Nephron Pharmaceuticals
Session 4 | Compliance Tips from the Trenches: How Effective Compliance is Good Business for Life Sciences Companies
- Presented by: Alice Harris of Nexsen Pruet and Tom Bolton of Pharmaceutical Associates, Inc.
Session 5 | Patent Basics for Life Science Companies
- Presented by: David Bradin of Nexsen Pruet and John Demos of KNOW Bio, LLC
Session 6 | Tales from the Front Lines: Managing Cyber Risk in the Life Sciences Industry
- Presented by: Nexsen Pruet attorneys Bryan Baysinger and Kirsten Small, CIPP/US
Session 7 | Understanding Clinical Research Framework and Challenges in the Life Sciences Industry
- Presented by: Matthew Roberts of Nexen Pruet and Rakel Meir of Biogen
Experience
Media
Events
Insights
Videos/Podcasts
Health care attorney Matthew Roberts discusses the significant impact of ESG, or Environmental, Social, and Governance, for life sciences companies.
Matthew Roberts examines the significant and sometimes positive changes occurring in clinical research processes in the life sciences industry caused by the COVID-19 pandemic.
Nexsen Pruet's newest webinar series is focusing on Life Sciences companies in the Carolinas. These webinars will focus on various legal and regulatory issues that Life Sciences companies deal with on a daily basis. They are also designed to provide updates and strategies on how to deal with these issues.
The future of the life sciences industry is bright in South Carolina. Nexsen Pruet's health care practice group leader Matthew Roberts highlights the economic impact of one of the State's fastest growing industry sectors.
Nexsen Pruet's newest webinar series is focusing on Life Sciences companies in the Carolinas. These webinars will focus on various legal and regulatory issues that Life Sciences companies deal with on a daily basis. They are also designed to provide updates and strategies on how to deal with these issues.
Nexsen Pruet's newest webinar series is focusing on Life Sciences companies in the Carolinas. These webinars will focus on various legal and regulatory issues that Life Sciences companies deal with on a daily basis. They are also designed to provide updates and strategies on how to deal with these issues.
Podcasts
- 10.04.2022 | Taking the Pulse: A Health Care & Life Sciences Podcast - Episode 115: Dr. Michael Havig, CEO, HealthMe
Matthew and Amanda welcome Dr. Michael Havig, HealthMe founder and CEO, to episode 115. Michael is an orthopedic surgeon and sports medicine specialist who created HealthMe to help patients find the best health care and save money while also helping providers grow revenues and simplify pricing. Tune in to hear Dr. Havig discuss how his engagement platform is a leader in the price transparency trend and his insights on the No Surprises Act!
Hosts Matthew Roberts and Amanda Loveday welcome their colleague Joe Dickinson, a Nexsen Pruet cybersecurity attorney, for episode 114. Joe discusses how matters of data governance, privacy, and cybersecurity are increasing concerns in the health care and life sciences sectors. They dive into what health care leaders should do to protect their business, meet regulations, and more.
- 09.20.2022 | Taking the Pulse: A Health Care & Life Sciences Podcast - Episode 113: with Ryan Loehr, Managing Director, AMB Wealth
On episode 113, Amanda Loveday and Darra James Colman sit down with the Managing Director of AMB Wealth, Ryan Loehr. They discuss his experience advising private equity firms and public companies across the health care and life sciences industries, the investment banking opportunities for health care and life sciences businesses, and much more. Tune in now!
StartUp Health is uniting entrepreneurs and investing in transformative innovation in the health care sector. On this episode, we're joined by their Chief Content Officer, Logan Plaster, who tells us about his work, StartUp Health's unique practices, and how the health care industry is evolving. Tune in!
On this episode we're joined by Will Britt, Chief Counsel for Public Health for the South Carolina Department of Health and Environmental Control. He offers up his perspective on how people's perception of public health has changed in the wake of a pandemic, what exactly his role is at the agency, and more.
- 08.18.2022 | Taking the Pulse: A Health Care and Life Sciences Podcast - Episode 110: Meg Kinnard and Vickie Eslinger
On this episode we're joined by Meg Kinnard, a journalist with the Associated Press, and Vickie Eslinger, Nexsen Pruet attorney, to discuss their health care experiences.
Matthew and Heather welcome back Sam Konduros to discuss his new role as President and CEO of KOR Medical. KOR Medical is a recently launched health innovation company that plans to set the standard in the arena of personalized, clinical cannabis to benefit patients suffering from diseases like epilepsy and cancer and to help alleviate the nationwide opioid crisis. Tune in now and learn more about this exciting South Carolina based company!
